BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 16400521)

  • 21. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice.
    Klenke FM; Gebhard MM; Ewerbeck V; Abdollahi A; Huber PE; Sckell A
    BMC Cancer; 2006 Jan; 6():9. PubMed ID: 16409625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of accelerated tumor growth in surgical wounds by celecoxib and indomethacin.
    Roh JL; Sung MW; Kim KH
    Head Neck; 2005 Apr; 27(4):326-32. PubMed ID: 15719392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelin-1 and endothelin-3 promote invasive behavior via hypoxia-inducible factor-1alpha in human melanoma cells.
    Spinella F; Rosanò L; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2007 Feb; 67(4):1725-34. PubMed ID: 17308114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis.
    Liou JY; Ellent DP; Lee S; Goldsby J; Ko BS; Matijevic N; Huang JC; Wu KK
    Stem Cells; 2007 May; 25(5):1096-103. PubMed ID: 17234991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
    Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
    Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of nociceptive behavior in prostaglandin E, F, D, prostacyclin and thromboxane receptor knockout mice.
    Popp L; Häussler A; Olliges A; Nüsing R; Narumiya S; Geisslinger G; Tegeder I
    Eur J Pain; 2009 Aug; 13(7):691-703. PubMed ID: 18938093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blocking tumor cell eicosanoid synthesis by GP x 4 impedes tumor growth and malignancy.
    Heirman I; Ginneberge D; Brigelius-Flohé R; Hendrickx N; Agostinis P; Brouckaert P; Rottiers P; Grooten J
    Free Radic Biol Med; 2006 Jan; 40(2):285-94. PubMed ID: 16413410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin-stimulated growth factor and cytokine expression in osteoblasts is mediated by protease-activated receptor-1 and prostanoids.
    Pagel CN; Song SJ; Loh LH; Tudor EM; Murray-Rust TA; Pike RN; Mackie EJ
    Bone; 2009 May; 44(5):813-21. PubMed ID: 19442625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of hematogenous melanoma brain metastases with endostatin.
    Kirsch M; Weigel P; Pinzer T; Carroll RS; Black PM; Schackert HK; Schackert G
    Clin Cancer Res; 2005 Feb; 11(3):1259-67. PubMed ID: 15709197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice.
    Ayoub SS; Colville-Nash PR; Willoughby DA; Botting RM
    Eur J Pharmacol; 2006 May; 538(1-3):57-65. PubMed ID: 16674937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of prostaglandin E2 (PGE2) production by arachidonic acid, oestrogen and parathyroid hormone in MG-63 and MC3T3-E1 osteoblast-like cells.
    Coetzee M; Haag M; Claassen N; Kruger MC
    Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):423-30. PubMed ID: 16198098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation and apoptosis in Clostridium difficile enteritis is mediated by PGE2 up-regulation of Fas ligand.
    Kim H; Rhee SH; Pothoulakis C; Lamont JT
    Gastroenterology; 2007 Sep; 133(3):875-86. PubMed ID: 17854595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin E receptor EP3 deficiency modifies tumor outcome in mouse two-stage skin carcinogenesis.
    Shoji Y; Takahashi M; Takasuka N; Niho N; Kitamura T; Sato H; Maruyama T; Sugimoto Y; Narumiya S; Sugimura T; Wakabayashi K
    Carcinogenesis; 2005 Dec; 26(12):2116-22. PubMed ID: 16051640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth.
    Amano H; Hayashi I; Endo H; Kitasato H; Yamashina S; Maruyama T; Kobayashi M; Satoh K; Narita M; Sugimoto Y; Murata T; Yoshimura H; Narumiya S; Majima M
    J Exp Med; 2003 Jan; 197(2):221-32. PubMed ID: 12538661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of norepinephrine or prostaglandin E2 on extracellular acidification rate of MCG 101, or K1735-M2 tumor cells.
    Nylund G; Andersson M; Haraldsson B; Delbro DS
    Life Sci; 2004 Aug; 75(14):1747-59. PubMed ID: 15268974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
    Hatazawa R; Ohno R; Tanigami M; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms behind COX-1 and COX-2 inhibition of tumor growth in vivo.
    Axelsson H; Lönnroth C; Andersson M; Lundholm K
    Int J Oncol; 2010 Nov; 37(5):1143-52. PubMed ID: 20878062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
    Zhao QT; Yue SQ; Cui Z; Wang Q; Cui X; Zhai HH; Zhang LH; Dou KF
    Life Sci; 2007 Jan; 80(5):484-92. PubMed ID: 17097688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of COX-2 independent induction of apoptosis and cell cycle block in human colon carcinoma cells after S- or R-ibuprofen treatment.
    Janssen A; Maier TJ; Schiffmann S; Coste O; Seegel M; Geisslinger G; Grösch S
    Eur J Pharmacol; 2006 Jul; 540(1-3):24-33. PubMed ID: 16730702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine-induced prostaglandin E2 production and cyclooxygenase-2 expression in dental pulp cells: downstream calcium signalling via activation of prostaglandin EP receptor.
    Chang MC; Chen YJ; Tai TF; Tai MR; Li MY; Tsai YL; Lan WH; Wang YL; Jeng JH
    Int Endod J; 2006 Oct; 39(10):819-26. PubMed ID: 16948668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.